Companies /Healthcare

Abbvie Inc

NYSE: ABBV Drug Manufacturers - General
$258.15
▼ $4.75 (−1.81%) today
Markets closed · 11:09pm ET

ABBV Coverage

Page 25
11:50am ET
Health and Healthcare

AbbVie Slides on Weak Midstage Results

AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small cell lung cancer trial.

Chris Lange